RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
TFA Therapeutics, Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026
$9.18+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns TFA Therapeutics's shares
No ownership filings found
No 13F institutional holdings, fund holdings or insider filings (Forms 3, 4 and 5) are on record for RAJAF.